T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
2101
DELISTED
Flushing Financial
FFIC
| $561K | ﹤0.01% |
22,998
-237
| -1% | -$6.12K |
|
2102
Power Integrations
POWI
$3.48B
| $559K | ﹤0.01% |
17,676
+264
| +2% | +$9.5K |
|
2103
Upbound Group
UPBD
$1.15B
| $558K | ﹤0.01% |
38,770
+270
| +0.7% | +$3.97K |
|
2104
Brookdale Senior Living
BKD
$3B
| $557K | ﹤0.01% |
56,658
+172
| +0.3% | +$1.58K |
|
2105
PUT
Macy's
M
$6.27B
| $556K | ﹤0.01% |
16,000
| – | – |
|
2106
Northern Oil and Gas
NOG
$2.61B
| $556K | ﹤0.01% |
13,909
-164
| -1% | -$5.54K |
|
2107
Rayonier Advanced Materials
RYAM
$570M
| $556K | ﹤0.01% |
30,169
+120
| +0.4% | +$2.36K |
|
|
MDC
2108
DELISTED
M.D.C. Holdings, Inc.
MDC
| $556K | ﹤0.01% |
21,941
+317
| +1% | +$8.5K |
|
|
CAMP
2109
DELISTED
CalAmp Corp.
CAMP
| $554K | ﹤0.01% |
1,005
-17
| -2% | -$9.07K |
|
2110
Altisource Portfolio Solutions
ASPS
$65.6M
| $552K | ﹤0.01% |
2,140
-30
| -1% | -$8.16K |
|
|
GES
2111
DELISTED
Guess Inc
GES
| $551K | ﹤0.01% |
24,394
-162
| -0.7% | -$3.67K |
|
|
TIVO
2112
DELISTED
Tivo Inc
TIVO
| $549K | ﹤0.01% |
44,126
+110
| +0.2% | +$1.42K |
|
2113
Corbus Pharmaceuticals
CRBP
$195M
| $544K | ﹤0.01% |
2,403
+10
| +0.4% | +$1.62K |
|
2114
Lindsay Corp
LNN
$1.17B
| $544K | ﹤0.01% |
+5,427
| New | +$510K |
|
|
CMRX
2115
DELISTED
Chimerix, Inc.
CMRX
| $544K | ﹤0.01% |
139,825
+255
| +0.2% | +$1.09K |
|
2116
Forrester Research
FORR
$224M
| $543K | ﹤0.01% |
11,823
-38
| -0.3% | -$1.75K |
|
|
NXTM
2117
DELISTED
NxStage Medical Inc.
NXTM
| $543K | ﹤0.01% |
19,468
-121
| -0.6% | -$3.4K |
|
|
JCP
2118
DELISTED
J.C. Penney Company, Inc.
JCP
| $534K | ﹤0.01% |
321,705
+1,091
| +0.3% | +$2.31K |
|
|
LGF.A
2119
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $533K | ﹤0.01% |
21,854
| – | – |
|
2120
Toyota
TM
$223B
| $532K | ﹤0.01% |
4,281
-281
| -6% | -$35.5K |
|
2121
Modine Manufacturing
MOD
$10.8B
| $529K | ﹤0.01% |
35,477
-503
| -1% | -$8.56K |
|
2122
Canterbury Park Holding Corp
CPHC
$81.4M
| $528K | ﹤0.01% |
34,647
| – | – |
|
|
PRMW
2123
DELISTED
Primo Water Corporation
PRMW
| $527K | ﹤0.01% |
29,180
+422
| +1% | +$7.83K |
|
2124
Acco Brands
ACCO
$399M
| $526K | ﹤0.01% |
46,570
+608
| +1% | +$7.8K |
|
2125
Simulations Plus
SLP
$370M
| $526K | ﹤0.01% |
26,035
+16,571
| +175% | +$324K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.